Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Kerry WentworthChief Regulatory Officer | Nuvation BioNUVB | Open-market sale10b5-1 plan | 06/23 | 06/24 | 63,000 sh | $6.02 | $379,260 | −54.3% |
Stacy MarkelChief People Officer | Nuvation BioNUVB | Open-market sale10b5-1 plan | 06/23 | 06/24 | 125,000 sh | $6.03 | $753,750 | −79.3% |
Nuvation BioNUVB | Open-market sale10b5-1 plan | 06/23 | 06/24 | 47,668 sh | $6.01 | $286,484.68 | −79.0% | |
Robert MashalDirector | Nuvation BioNUVB | Open-market buy | 06/09 | 06/11 | 25,000 sh | $4.73 | $118,250 | +12.5% |
Kerry WentworthChief Regulatory Officer | Nuvation BioNUVB | Open-market sale10b5-1 plan | 04/17 | 04/21 | 36,750 sh | $5.01 | $184,117.5 | −40.9% |
Dongfang LiuChief Medical Officer | Nuvation BioNUVB | Open-market sale10b5-1 plan | 04/17 | 04/21 | 50,000 sh | $5.02 | $251,000 | −73.5% |
Kerry WentworthChief Regulatory Officer | Nuvation BioNUVB | Open-market sale10b5-1 plan | 04/06 | 04/08 | 200,000 sh | $4.52 | $904,000 | −79.1% |
Dongfang LiuChief Medical Officer | Nuvation BioNUVB | Open-market sale | 25/12/01 | 25/12/03 | 150,000 sh | $7.82 | $1,173,000 | −89.3% |
Nuvation BioNUVB | Open-market sale | 25/11/25–25/11/26 | 25/11/26 | 20,000 sh2 trades | $7.75avg. | $155,000 | −52.6% | |
Nuvation BioNUVB | Open-market sale | 25/11/20 | 25/11/24 | 369,051 sh2 trades | $7.23avg. | $2,668,238.73 | −100.0% | |
Dongfang LiuChief Medical Officer | Nuvation BioNUVB | Open-market sale | 25/11/20 | 25/11/24 | 20,000 sh | $7.00 | $140,000 | −52.6% |
David C. HanleyChief Technical Operations | Nuvation BioNUVB | Open-market sale | 25/11/19 | 25/11/21 | 200,000 sh | $7.14 | $1,428,000 | −89.3% |
Nuvation BioNUVB | Open-market sale | 25/11/17–25/11/19 | 25/11/19 | 30,000 sh2 trades | $4.94avg. | $148,050 | −62.5% | |
Gary HattersleyChief Scientific Officer | Nuvation BioNUVB | Open-market sale10b5-1 plan | 25/10/27 | 25/10/29 | 100,000 sh | $5.02 | $502,000 | −100.0% |
Stacy MarkelChief People Officer | Nuvation BioNUVB | Open-market buy | 25/06/18 | 25/06/18 | 10,000 sh | $1.71 | $17,100 | +51.0% |
Nuvation BioNUVB | Open-market buy | 25/06/16–25/06/17 | 25/06/18 | 7,300 sh2 trades | $1.81avg. | $13,232 | +280.6% | |
David HungPresident and CEO | Nuvation BioNUVB | Open-market buy | 25/06/16 | 25/06/18 | 500,000 sh | $1.79 | $895,000 | +0.9% |
Nuvation BioNUVB | Open-market buy | 25/06/16 | 25/06/18 | 50,000 sh2 trades | $1.79avg. | $89,740 | No record | |
Colleen SjogrenChief Commercial Officer | Nuvation BioNUVB | Open-market buy | 25/06/16 | 25/06/18 | 50,000 sh | $1.81 | $90,500 | +161.3% |
Dongfang LiuChief Medical Officer | Nuvation BioNUVB | Open-market sale10b5-1 plan | 25/05/02 | 25/05/06 | 20,000 sh | $2.50 | $50,000 | −62.5% |